Neurocrine Biosciences (0K6R.L) Stock Price
$143.9 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
8 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Neurocrine Biosciences, AI stock picks, stock alerts and much more.
0K6R.L AI Stock Analysis
Financial Performance
Neurocrine Biosciences reported a revenue of $572.6M last quarter, which is down by -8.8% from the previous quarter and down by -3% year over year. The gross profit was also down at $563.4M, showing a decrease of -8.9% from the previous quarter and -1.9% year over year. The operating income profit significantly decreased as well to $23.6M, dropping by -83.4% from the previous quarter and an alarming drop of -84% year over year.
The EBITDA ratio for the last quarter was 0.04 indicating marginal profitability of the company.
Stock Price
The current stock price is trading at $143.9 which has seen an increase of 8.2% in the last month, and an appreciable increase of 21.1% YoY (year on year). However, with a PE ratio standing high at 197.12 it indicates that the stock might be overvalued.
The RSI value stands at 65.92 indicating that it's nearing an overbought territory while its current price is considerably higher than its 200-day moving average ($114) suggesting bullishness in recent times.
Alternative Data Signals
In terms of website traffic trends, Neurocrine Biosciences' web traffic has seen a slight decline with estimated visitors per month dropping by -11%. On the job front, there are currently 85 openings which is up by 18%, suggesting potential expansion or replacement needs within the company.
Around three-quarters (75%) employees report having a positive business outlook despite this being a decrease of -8.5% MoM (month on month) and -15.7% YoY.
Neurocrine Biosciences' social media presence has seen significant growth with Twitter followers increasing by 22.1% in the last 90 days, and Facebook followers up by an impressive 163.9% in the same period.
Conclusion
In conclusion, while Neurocrine Biosciences' stock price has shown promising growth recently, there are concerns regarding its financial performance with decreasing revenue and profits. The company's web traffic is also declining but it does show positive signs in terms of job openings and growing social media presence.
The outlook for Neurocrine Biosciences' stock is neutral to slightly bullish given the recent upward trend in stock price despite some negative indicators in financial performance and employee business outlook.
Neurocrine Biosciences (0K6R.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Neurocrine Biosciences (0K6R.L), currently trading at $143.9, will... Sign up to access price prediction.
About 0K6R.L
-
Neurocrine Biosciences, Inc.
-
Symbol
0K6R.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
14.3B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$385 0.8% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.21 3.7% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.54 3% |
4 |
 |
Esperion Therapeutics 0IIM.L |
$2.75 0.2% |
5 |
 |
Thermo Fisher Scientific Inc. 0R0H.L |
$480.5 0.5% |
6 |
News
No news articles.
0K6R.L Alternative Data
Web Traffic
Neurocrine Biosciences receives an estimated 33666 monthly visitors to neurocrine.com.
-
Web Traffic
33666
-
Change from Previous Month
11.9%
-
3 Month Change
28.6%
-
YoY Change
28.6%
Twitter Followers
Neurocrine Biosciences has 802 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.9% over the last month.
-
Twitter Followers
802
-
Daily Change
0.1%
-
1 Month Change
1.9%
-
3 Month Change
5.8%
-
YoY Change
5.8%
Facebook Engagement
Neurocrine Biosciences has engaged 24 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
24
-
Daily Change
31.4%
-
1 Month Change
380%
-
3 Month Change
118.2%
-
YoY Change
118.2%
Job Postings
Neurocrine Biosciences currenly has an estimated 85 open job postings, up by 7.6% over the last month.
-
Job Postings
85
-
Daily Change
6.3%
-
1 Month Change
7.6%
-
3 Month Change
6.3%
-
YoY Change
6.3%
Reddit Mentions
Neurocrine Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
79,591 are following Neurocrine Biosciences on LinkedIn, up by 1.8% over the last month.
-
LinkedIn Followers
79591
-
Daily Change
1.8%
-
1 Month Change
1.8%
-
3 Month Change
6.6%
-
YoY Change
6.6%
LinkedIn Employees
According to LinkedIn, Neurocrine Biosciences has 1,998 employees, up by 0.7% over the last month.
-
LinkedIn Employees
1998
-
Daily Change
0.7%
-
1 Month Change
0.7%
-
3 Month Change
3.5%
-
YoY Change
3.5%
Business Outlook
According to employee reviews, the business outlook among employees at Neurocrine Biosciences is 75 out of 100 (bullish).
-
Business Outlook
75
-
Change from Previous Month
8.5%
-
3 Month Change
9.6%
-
YoY Change
9.6%
News Mentions
Neurocrine Biosciences was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0K6R.L Financials
0K6R.L Key Metrics
-
Total Revenue
$572.6M
-
Net Income
$7.9M
-
Earnings per Share
$0.08
-
Free cash flow
$54.1M
-
EBITDA
$23.6M
-
EBITDA Ratio
0.0412155
-
Total Assets
$3.7B
0K6R.L 2-year Revenue & Income
0K6R.L 2-year Free Cash Flow
0K6R.L Technicals
0K6R.L SMA
0K6R.L RSI
FAQ
What's the current price of Neurocrine Biosciences (0K6R.L) Stock?
The price of an Neurocrine Biosciences (0K6R.L) share is $143.9.
What's the market cap of Neurocrine Biosciences?
The current market cap of Neurocrine Biosciences is 14.3B.
What are some stocks similar to Neurocrine Biosciences (0K6R.L) that investors often compare it to?
Neurocrine Biosciences (0K6R.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Emergent BioSolutions Inc., Abeona Therapeutics Inc., Esperion Therapeutics and Thermo Fisher Scientific Inc..
What is the forecast for Neurocrine Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Neurocrine Biosciences' stock price to be around $149.9 in 2026. Starting from the current price of $143.9, this represents a 4.1% change in price, indicating a neutral outlook for the stock.
How to buy Neurocrine Biosciences (0K6R.L) Stock?
Neurocrine Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Neurocrine Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.